Sign In
Buy EVFM
$0.0080
+0.0015 (+23.08%)
At Close: Jun 03, 2026
Evofem Reports First Quarter 2026 Financial Results and Provides Business Update
08:55am, Monday, 18'th May 2026
SAN DIEGO--(BUSINESS WIRE)---- $EVFM #BV--Women's health innovator Evofem Biosciences, Inc. (Evofem or the Company) (OTCID: EVFM), today announced financial results for the first quarter ended March 3
Evofem Announces Exclusive Agreement for the Distribution and Commercialization of SOLOSEC in Sub-Saharan Africa
09:25am, Monday, 27'th Apr 2026
SAN DIEGO--(BUSINESS WIRE)---- $EVFM #BV--Women's health innovator Evofem Biosciences, Inc. (OTCID: EVFM) (Evofem or the Company) today announced that it has entered into an exclusive Distribution Agr
Head-To-Head Survey: Evofem Biosciences (NASDAQ:EVFM) and Ayala Pharmaceuticals (NASDAQ:ADXS)
02:50am, Thursday, 26'th Mar 2026
Valuation and Earnings This table compares Ayala Pharmaceuticals and Evofem Biosciences"s gross revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per
Evofem Reports Fifth Consecutive Year of Net Sales Growth
04:05pm, Wednesday, 11'th Mar 2026
SAN DIEGO--(BUSINESS WIRE)---- $EVFM #BV--Women's health pioneer Evofem reported its fifth consecutive year of top line growth, with 2025 net product sales of more than $20 million.
Evofem CEO Saundra Pelletier Calls for a “Ground-Up Reset” of Women's Health at Fierce JPM Week 2026
09:25am, Friday, 23'rd Jan 2026
SAN DIEGO--(BUSINESS WIRE)---- $EVFM #Fierce--Evofem CEO's fiery keynote address at Fierce JPM Week 2026 calls for “Ground-Up Reset” of Women's Health. Replay now live at fiercejpmweek.com.
Evofem Expands “Say Vagina” Campaign With Launch of Say Vagina Store
11:00am, Wednesday, 21'st Jan 2026
SAN DIEGO--(BUSINESS WIRE)---- $EVFM #sayvagina--Evofem launched SayVaginaStore.com, expanding its 'Say Vagina' campaign addressing widespread censorship of female anatomical terms in the media.
Financial Contrast: Evofem Biosciences (NASDAQ:EVFM) and BetterLife Pharma (OTCMKTS:PVOTF)
01:13am, Monday, 29'th Dec 2025
Earnings and Valuation This table compares BetterLife Pharma and Evofem Biosciences"s revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Ear
Evofem Biosciences (NASDAQ:EVFM) Stock Passes Above 50 Day Moving Average – What’s Next?
02:06am, Friday, 26'th Dec 2025
Evofem Biosciences, Inc. (NASDAQ: EVFM - Get Free Report)'s stock price crossed above its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $0.01 and traded as
Head to Head Contrast: Evofem Biosciences (NASDAQ:EVFM) versus Vaccinex (NASDAQ:VCNX)
01:46am, Thursday, 25'th Dec 2025
Valuation and Earnings This table compares Evofem Biosciences and Vaccinex"s top-line revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Ear
— PHEXX® Poised to Become First and Only Hormone-Free Contraceptive Vaginal Gel Approved in UAE — — 2026 Launch Planned for Hormone-Free Contraceptive in UAE — SAN DIEGO , Nov. 21, 2025 /PR
Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update
04:05pm, Thursday, 13'th Nov 2025
-- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter -- -- Delivered $1.0 Million of Operating Income in Q3 2025 -- SAN DIEGO , Nov. 13, 2025 /PRNewswire/ -- Women's
Evofem Biosciences (NASDAQ:EVFM) & Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Head-To-Head Survey
01:32am, Sunday, 02'nd Nov 2025
Profitability This table compares Evofem Biosciences and Calliditas Therapeutics AB (publ)'s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Evofem Bi
Evofem Announces Voting Results from Special Meeting of Stockholders
04:19pm, Monday, 20'th Oct 2025
-- Evofem Shareholders Did Not Approve the Merger with Aditxt -- -- Evofem Pivots to Target National Listing for Stock, Growth Capital to Catalyze Net Sales -- SAN DIEGO , Oct. 20, 2025 /PRNewswire/ -
Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates
08:47am, Wednesday, 01'st Oct 2025
— First ex-U.S. Regulatory Filing for SOLSOEC® — — Pharma 1 Targets 1H 2026 Launch in UAE for SOLOSEC® to Treat Bacterial Vaginosis and Trichomoniasis, leveraging its commercial infrastru
Evofem Biosciences Honors World Contraception Day
08:15am, Friday, 26'th Sep 2025
SAN DIEGO , Sept. 26, 2025 /PRNewswire/ -- On World Contraception Day, Evofem Biosciences, Inc. ("Evofem" or "the Company") (OTCID: EVFM) honors the millions of people worldwide who rely on contracept
